Newest figures come from the 10-Q for Q1 FY2027, filed Nov 12, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the TBNRL SEC filings page.
Tamboran Res Corp CDI (TBNRL) reported $0 in revenue over the twelve months to Sep 30, 2026. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
FY2026 shows an investment-funded development business: losses persist while financing builds the asset base faster than operations generate cash.
In FY2026, operating cash flow was-$34.6M while financing cash flow supplied$412.3M , so expansion was funded externally rather than by internal cash generation. That pattern aligns with total assets rising158.5% from FY2025 while liabilities rose only16.2% , indicating the balance-sheet step-up came chiefly through equity financing.
The earnings-to-cash relationship is unfavorable: FY2026 net loss was
The balance sheet became more equity-heavy: current ratio recovered to 2.6x from 1.5x, giving near-term assets more coverage of current obligations. Liabilities were
Financial Health Signals
We do not publish a peer-relative financial health score for Tamboran Res Corp CDI, because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.
Tamboran Res Corp CDI scores 3.01, well above the 2.99 safe threshold. The largest contribution to the score comes from a market capitalization of $978.9M against total liabilities of $184.4M. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Tamboran Res Corp CDI passes 2 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, the one computable operating efficiency signal (asset turnover improving) does not pass.
Tamboran Res Corp CDI reported a net loss of $26.1M while operations used $34.6M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Tamboran Res Corp CDI reported an operating loss of $32.7M against $334K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Tamboran Res Corp CDI generated $0 in revenue in Q1 2027. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Tamboran Res Corp CDI's EBITDA was -$11.9M in Q1 2027, measuring earnings before interest, taxes, depreciation, and amortization. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Tamboran Res Corp CDI reported a net loss of $12.1M in Q1 2027. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Cash & Balance Sheet
Tamboran Res Corp CDI held $160.1M in cash against $67.5M in long-term debt as of Q1 2027.
Not reported for Q1 2027.
Not reported for Q1 2027.
Margins & Returns
Tamboran Res Corp CDI's quarterly ROE was -1.5% in Q1 2027: one quarter's net income over shareholder equity, not annualized. This is up 1.3 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.3 percentage points.
Not reported for Q1 2027.
Not reported for Q1 2027.
Not reported for Q1 2027.
Capital Allocation
Tamboran Res Corp CDI invested $8K in research and development in Q1 2027. This represents a decrease of 95.8% from the same quarter a year earlier.
Not reported for Q1 2027.
Not reported for Q1 2027.
TBNRL Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| R&D Expenses | $8K-95.8% | N/A | $31K-98.4% | $136K-95.8% | $191Kn/m | N/A | $2.0Mn/m | $3.2Mn/m |
| SG&A Expenses | $2.2M+35.3% | $1.9M | $1.5M+2.8% | $1.7M+20.7% | $1.6M+13.7% | N/A | $1.5M+109.5% | $1.4M+30.9% |
| Operating Income | -$11.9Mn/m | -$8.3M | -$8.4Mn/m | -$7.8Mn/m | -$8.2Mn/m | N/A | -$8.8Mn/m | -$15.0Mn/m |
| EBITDA | -$11.9Mn/m | -$8.3M | -$8.4Mn/m | -$7.8Mn/m | -$8.2Mn/m | N/A | -$8.8Mn/m | -$15.0Mn/m |
| Interest Expense | N/A | N/A | N/A | N/A | $305K | N/A | N/A | N/A |
| Net Income | -$12.1Mn/m | -$1.9M | -$9.4Mn/m | -$6.6Mn/m | -$8.2Mn/m | N/A | -$6.7Mn/m | -$14.2Mn/m |
| EPS (Basic) | -$0.35 | N/A | -$0.42 | -$0.33n/m | -$0.47n/m | -$0.65n/m | -$0.46n/m | -$0.99 |
| EPS (Diluted) | -$0.35 | N/A | -$0.42 | -$0.33n/m | -$0.47n/m | -$0.65n/m | -$0.46n/m | -$0.99 |
| Diluted Shares (Avg) | 35M | N/A | 22M | 20M+39.6% | 18M+24.1% | N/A | 15M+42.2% | 14M |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, Income Tax.
TBNRL Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.2B+147.7% | $1.2B+158.5% | $672.1M+76.2% | $600.6M+65.5% | $484.2M+27.0% | $446.5M+24.5% | $381.5M | $362.9M |
| Current Assets | $191.3M+311.8% | $243.2M+328.9% | $118.1M+211.2% | $106.4M+58.0% | $46.5M-48.4% | $56.7M-41.7% | $37.9M | $67.3M |
| Cash & Equivalents | $160.1M+304.7% | $219.1M+455.6% | $88.2M+243.9% | $83.4M+40.3% | $39.6M-46.6% | $39.4M-47.2% | $25.6M-1.1% | $59.4M+79.2% |
| Short-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Long-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Total Liabilities | $192.0M+1.6% | $184.4M+16.2% | $276.5M+95.2% | $241.7M+348.7% | $189.0M+248.9% | $158.7M+211.5% | $141.7M | $53.9M |
| Current Liabilities | $94.2M+87.2% | $93.1M+154.2% | $59.1M+71.9% | $53.0M+39.2% | $50.3M+45.0% | $36.6M+30.7% | $34.4M | $38.1M |
| Non-Current Liabilities | $97.9M+429.6% | $91.4M+347.8% | $66.4M+204.4% | $56.8M+259.3% | $18.5M-5.1% | $20.4M-11.1% | $21.8M | $15.8M |
| Long-Term Debt | $67.5M | $59.0Mn/m | $44.6M | $32.6Mn/m | N/A | $0 | N/A | $0 |
| Total Equity | $800.2M+171.1% | $796.2M+176.7% | $395.6M+64.9% | $358.9M+47.1% | $295.1M+7.1% | $287.7M+9.5% | $239.8M | $243.9M |
| Retained Earnings | -$205.5Mn/m | -$193.4Mn/m | -$191.5Mn/m | -$182.1Mn/m | -$175.5Mn/m | -$167.3Mn/m | -$157.1M | -$150.4M |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill.
TBNRL Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$10.2Mn/m | -$7.6Mn/m | -$12.5Mn/m | -$707Kn/m | -$13.8Mn/m | -$6.4Mn/m | -$14.3Mn/m | -$4.7Mn/m |
| Depreciation & Amortization | $2K0.0% | $2K+100.0% | $2K-91.3% | $2K-93.5% | $2K-93.5% | $1K-96.7% | $23K-27.7% | $31K+6.6% |
| Stock-Based Compensation | $2.6M+1127.4% | N/A | N/A | N/A | $215K-81.0% | N/A | N/A | N/A |
| Investing Cash Flow | -$94.4Mn/m | -$74.8Mn/m | -$46.3Mn/m | -$38.1Mn/m | -$28.4Mn/m | -$25.1Mn/m | -$37.9Mn/m | -$21.3Mn/m |
| Financing Cash Flow | $41.2M+8.6% | $218.2M+314.0% | $60.6M+256.5% | $95.6M+553.8% | $37.9M+126.6% | $52.7M-25.0% | $17.0M+42.7% | $14.6M-51.0% |
Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.
TBNRL Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Return on Equity | -1.5%+1.3pp | -0.2% | -2.4%+0.4pp | -1.8%+4.0pp | -2.8%-0.6pp | N/A | -2.8% | -5.8% |
| Return on Assets | -1.0%+0.7pp | -0.2% | -1.4%+0.3pp | -1.1%+2.8pp | -1.7%-0.1pp | N/A | -1.7% | -3.9% |
| Current Ratio | 2.03+1.1x | 2.61+1.1x | 2.00+0.9x | 2.01+0.2x | 0.92-1.7x | 1.55-1.9x | 1.10 | 1.77 |
| Debt-to-Equity | 0.08 | 0.07+0.1x | 0.11 | 0.09+0.1x | N/A | 0.00 | N/A | 0.00 |
| Liabilities-to-Equity | 0.24-0.4x | 0.23-0.3x | 0.70+0.1x | 0.67+0.5x | 0.64+0.4x | 0.55+0.4x | 0.59 | 0.22 |
| Asset Turnover | 0.000.0x | 0.000.0x | 0.000.0x | 0.000.0x | 0.000.0x | 0.000.0x | 0.00 | 0.00 |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Tamboran Res Corp CDI TBNRL | FY2026 | $0 | -$26.1M | N/A | $978.9M | — |
| Zion Oil & Gas Inc ZNOG | FY2025 | N/A | -$7.6M | N/A | $351.2M | — |
| BioForce Nanosciences HLD BFNH | FY2025 | N/A | -$1.3M | N/A | $255.0M | — |
Where Tamboran Res Corp CDI Ranks
Frequently Asked Questions
Tamboran Res Corp CDI (TBNRL) reported $0 in total revenue for fiscal year 2026. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
No, Tamboran Res Corp CDI (TBNRL) reported a net loss of $30.0M over the trailing 12 months to September 30, 2026. In fiscal year 2026 it reported a net loss of $26.1M.
Tamboran Res Corp CDI (TBNRL) had EBITDA of -$32.7M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.
As of fiscal year 2026, Tamboran Res Corp CDI (TBNRL) had $219.1M in cash and equivalents against $59.0M in long-term debt.
Tamboran Res Corp CDI (TBNRL) has a return on equity of -3.3% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.
Tamboran Res Corp CDI (TBNRL) recorded an outflow of $34.6M in operating cash flow during fiscal year 2026, representing cash used by core business activities.
Tamboran Res Corp CDI (TBNRL) had $1.2B in total assets as of fiscal year 2026, including both current and long-term assets.
Tamboran Res Corp CDI (TBNRL) invested $123K in research and development during fiscal year 2026.
Tamboran Res Corp CDI (TBNRL) had a current ratio of 2.61 as of fiscal year 2026, which is generally considered healthy.
Tamboran Res Corp CDI (TBNRL) had a debt-to-equity ratio of 0.07 as of fiscal year 2026. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
Tamboran Res Corp CDI (TBNRL) had a liabilities-to-equity ratio of 0.23 as of fiscal year 2026, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
Tamboran Res Corp CDI (TBNRL) had a return on assets of -2.3% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
At the end of fiscal year 2026, Tamboran Res Corp CDI (TBNRL) held $219.1M in cash, cash equivalents and investments, and reported an operating cash outflow of $34.6M over that year. Dividing the one by the other, the reported balance equals about 76 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
Tamboran Res Corp CDI (TBNRL) has an Altman Z-Score of 3.01, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
Tamboran Res Corp CDI (TBNRL) has a Piotroski F-Score of 2 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Tamboran Res Corp CDI (TBNRL) reported a net loss of $26.1M while operations used $34.6M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Tamboran Res Corp CDI (TBNRL) reported an operating loss of $32.7M against $334K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.